emeritus
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not a bad day considering. Franchisee bails on brand. Trolls exposed. Shareholder update bereft of actual content. Just file your financials droopy. All the pain goes away.
$evio likely still has access to that sweet sweet 3% franchise income for “expertise” what they have lost though is significant in the form of all that very professional, very extensive free media access that Kaycha was delivering on a regular basis thru major/ national TV / Media exposure. Now it’s back to droopy will and his nonsensical ramblings and never exposure.
The claims of a “stagnant” California testing marketplace might be true. Or it could be a vote by the marketplace on a lack of trust in the Evio brand. Which today’s announcement from Kaycha surely represents. Same as Canada. They’ve removed any branding/ mention or association with evio from all of their properties.
It’s truly a disappointment that the ego of one tyrant was allowed to destroy a company and hundreds of shareholders to the altar of his ego.
My bad -
My bad -
$evio update wasn’t posted here on ihub - not linked on evio twitter. Not posted on evio website - evio instagram deleted. Evio Florida and Evio New York are ....poof gone. Is evio inc next? Lawsuits flying, prison cell waiting - stay tuned for the ongoing spectacular self destruction of millions on shareholder value by William H Waldrop and Lori Glauser
@EVIO_Labs instagram account deleted. Good thing we screen capped all the posts for posterity and legal
This coming from the alleged insider with an intimate relationship to Kaycha Holdings. Was the dropping of the Evio Labs brand today by all Kaycha Labs in Florida / Colorado / NY / Arizona a big surprise? A big vote of confidence? Or another great big turd stinking up waldroopys corrupt leadership of this deal?
He’s like a private investigator of really shady dirty pubco deals specializing in cannabis. He used to comment on Waldrop constantly until Waldrop threatened him with slander litigation. Considering a derivative shareholder suit now and he might be a great asset. If you’d consider joining in for a pound of flesh from that fat pig thief Waldroopy. Drop me a dm
Of course. That’s clear. It’s pretty obvious that by changing the name of the companies labs in Florida, New York, Colorado and Arizona that says it all as to kaychas belief in Waldroopys management skill.
The whole - lets associate with a national public company to garner great nationwide free media exposure while we build out our own deal. Turned into - hey, it appears that we are the ones providing free national media exposure to a dumpster fire of a deal led by a management team of liars with zero skills and zero self awareness as to how terrible they are at their jobs and their personal exposure to massive lawsuits.
EVIO Inc. Provides Update on Status of Financials, Operations and Guidance on Company Outlook
September 24, 2019 09:39 AM Eastern Daylight Time
HENDERSON, Nev.--(BUSINESS WIRE)--EVIO Inc. (the “Company” or “EVIO”) (OTCQB:EVIO) provides an update on fiscal 2018-2019 financial statements and outstanding quarterly results, highlights and clarifies on current operations, and provides guidance on future growth.
EVIO Labs provides corporate update.
Tweet this
Financial Statements
In February 2019, the Company transitioned to a new auditor, BF Borgers CPA PC, in order to assist and facilitate expedited issuance of the Company’s outstanding financial reports. The Auditor is a US-based accounting firm with extensive experience working with US-based Cannabis and CBD-focused companies trading on the OTC markets. The 10k for the fiscal year 2018 was filed in August, 2019 and the Company is now working with the auditor to complete the remaining quarterly reports. The Company has been required to complete external audits on all acquired entities as well as the accounting of each of those acquired companies. These mandatory audits have added significant time delays to the issuance of our financial results. Working with BF Borgers over the last 6 months, the Company has made great progress towards getting financial reports up to current status. Updates will be provided on progress as they come available.
2018 Fund Raising
The Company began raising funds in 2018 for the purpose of executing specific growth objectives. EVIO successfully raised a portion of the funds required. Due to the market sentiment gauged in late 2018 the Company made the decision not to proceed with the second tranche of the raise. To compensate for a change in market trends, EVIO has altered focus from aggressive market expansion to increasing overall profitability through revenue retention and optimizations of current operations. Initiatives the Company has already undertaken to increase profitability include: restructuring lab development, growth, and operations; increasing and expanding the capabilities and accreditations of existing labs; and shifting Company focus to initiatives that provide immediate profitability. Management believes that focusing on profitability and maximizing the efficiency and capabilities in existing revenue generating labs is the optimal strategy to growing the company in the current market conditions will provide the greatest return of value to shareholders.
Operations
From an operational standpoint, the Company has achieved numerous key milestones across all labs since the last company update. EVIO now serves the entire state of Oregon from two licensed facilities, EVIO Portland and EVIO Medford. The Company consolidated four lab locations into one new company-owned building in Tigard, Oregon. The consolidation resulted in material reductions to overhead expenses by eliminating the leasing expenses of three facilities while maintaining the ability to serve the entire state. In addition, the Company recently expanded its ORELAP accreditation at EVIO Medford to include residual solvent testing. This will greatly increase throughput and improve the Company’s customer service capabilities in Southern Oregon. The Company also completed the ISO 17025 audit assessments and can now support Oregon’s rapidly growing hemp industry. EVIO Portland is awaiting approval from ORELAP to obtain accreditation for pesticide testing. Currently, the Company tests all pesticides in Medford, but with this new capability in the Portland lab, operations will be greatly improved. As a result the Company will increase its capacity to service a greater number of customers in a more efficient manner.
EVIO’s California operations have seen a number of strategic initiatives take place. EVIO Labs Berkeley has been granted its provisional license pursuant to an extensive audit of the lab’s testing methods. The Berkeley lab is one of only twenty-seven licensed laboratories in California that collectively serve more than one thousand licensed distributors across the state. Consistent with the Company’s focus on increasing profitability, the Company has increased sales efforts in the state by converting the Company’s Humboldt facility into a field sales office. All testing of the area has been consolidated into the Berkeley lab. In other areas of the state the Company continues to make headway in an uncertain market. The market conditions for cannabis compliance testing have changed, with growth remaining relatively flat. Testing demand has been an average of 1,000 tests per week per Bureau of Cannabis Control. Although volume is anticipated to increase with the required implementation and monitoring of the seed to sale tracking system, legislative progress towards this is slow. EVIO has been granted a Conditional Use Permit to operate a lab in Palm Desert, California and is assessing market conditions prior to proceeding with lab build-out.
In Canada, the Company’s subsidiary, Keystone Labs, recently completed installation and acceptance of heavy metal testing capability and is now in a position to be able to perform all Health Canada mandated tests required for cannabis. The increase in capabilities at Keystone Labs strategically coincides with the new wave of products entering Canada’s market following the much anticipated legalization of cannabis edibles, concentrates, and topicals on October 17th, 2019. The demand for testing to ensure these new consumer packaged goods and products meet quality and safety measures will be a positive catalyst for our revenues and profitability.
The company completed buildout of the new EVIO Labs Massachusetts location in Framingham, and received its Occupancy Permit in June, 2019. The company has since been performing re-accreditation activities in preparation for final state licensing procedures. We are in the final stages of licensing, and expect to be one of only four operating labs in the state once we resume operations.
Future Growth
In terms of the future, the Company has launched a comprehensive hemp/CBD marketing campaign and has set up a new website www.hemptesting.com to automate orders. The new website, which since its launch has received orders from around the world, and associated operational improvements have allowed the company to greatly expand reach and presence in the global cannabis market. Revenue from hemp and CBD products is anticipated to quickly overtake cannabis testing revenues. The new website and marketing campaign capitalize on this and align with the Company’s new focus on maximizing profitability, as well as demonstrate the Company’s ability to quickly adapt to changing market trends. EVIO Inc. remains focused on achieving optimal growth and leverage opportunities as they come available. There has been a recent focus in the news on the safety of vape pens and the contribution to severe lung disease due to vitamin E acetate. EVIO has received many inquiries regarding concerns to this matter from all over the U.S. The Company is actively evaluating the issue and expects to work with its regulatory agencies to help address testing needs. This is another new opportunity for expanding our capabilities within our existing labs to address a real market need. The Company will provide further guidance on future developments as they come available.
“The last 12 months have been a transitional time for EVIO Labs as we adjust to the changing market conditions,” said William Waldrop, CEO of EVIO Inc. “With the passing of the 2018 Farm Bill, there has been a dynamic shift within the industry to produce more Hemp-derived CBD products along with states developing new legislation to test CBD products at the same levels as cannabis. Our new hemptesting.com website is helping educate the industry as well as providing a platform for consistent ISO accredited testing to support this new burgeoning industry.”
Please share with us any quotes on the character and trustworthiness of Willy Wally Droopy Dick. Love to hear those. Anonymous of course. It’s unbelievable that a person so mentally unbalanced and focused so exclusively on their own ego can maintain control. Everyday in every way referendums are being made on his leadership and he continues to maintain its “outside circumstances and/or everyone else’s fault it his”
Lose two licenses for negligence and a criminal conspiracy after the fact to conceal the crimes as published in the ORELAP documents. Glauser still has a job and it’s the system out to get them.
Lose the cross list into Canada because you don’t know how to properly maintain financial record keeping to provide succinct audited financials to the Canadian regulators. Fire 3 CFO’s and auditing firm and blame market conditions.
Waste $1.5m on licensing and carrying costs in California.
Waste $2m on Colorado lab acquisition and carrying costs and sell 3% for 500k
Lose the confidence of the Florida licensee - the only positive media presence in the entire deal so far S to drive them to drop your brand in Florida. Colorado. New York. Arizona.
Keystone labs in Canada has removed all mention of any association with evio from all of its media and social properties.
The one Constant in all of this is Will Waldrop. Who still remains. While everything else is gone. Of course being a crazy self absorbed thin skinned narcissistic raging dictator Waldroopy isn’t self aware enough to imagine this.
But for a moment imagine a company where Waldroopy is as gone and all the other things were still there.
Time for the lawsuit I guess. Stay tuned.
No mention of Florida. It’s like they never existed. They lost all the money invested in Colorado and all the money invested in Florida - and now they’ve lost everything. And don’t even mention a word of it. Pretend like it never happened. Typical chicken bleep coward management.
5 weeks to file a quarterly and now we’re told we will be updated on the timing of its release. Basically admitting it’s not coming out anytime soon. So the company will remain delinquent and we can anticipate the 2019 10k due December 30 to be delinquent.
Btw- love the excuse “due to market conditions” excuse on the reason they didn’t do a second funding tranche. Replace that with “the funding people informed us our management team was the single worst one they’d ever met in history and informed us that unless Waldrop and Glauser were terminated, no more money - in keeping with our track record of great decisions - we kept management and said no to funding”
So the company is now dead. Losing the only quality piece of the deal in Florida, Colorado and NY and it’s goodwill. Media exposure. It’s all over but the lawsuits. Stay tuned for those.
Alan Borchstein. You’re our only hope.
Buying or selling this security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.
Anyone interested in what a pumper is and does. Let’s break down a recent post to this board.
A pumper can be spotted typically by making big grand pompous statements of fortune and bliss with zero evidence other than their own statements
Warning! This company may not be making material information publicly available
Buying or selling this security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties. $evio
This is the message greeting investors on the otc market site when you seek a quote of $evio stock. And you’re wondering why people might be concerned. And raising those concerns often. Because the company isn’t communicating. At all. Face the music or face the abuse. It’s up to you Waldrop.
Genius. 2$ stock before willy wally show deflated the price and blew up his waistline. Toxic debt holders pinata the stock up and down from 20-50 cents at will. Another small cap mastermind promoting the "short seller" narrative for a mismanaged dog. Almost as reliable as someone selling chart tracking.
Replace management. Get current. Open MASS. Cross into Canada. Open Biotech Research division.
Blah blah nonsense hot air blah - $evio hasn’t issued an expansion plan because they haven’t issued a PR in 10 months. They are currently in delinquency with the SEC and the OTC because their financial reporting is now 10 months late. They haven’t had a shareholder meeting for two years. Their CEO is hiding like a beat dog scared of its own shadow. Get your mr magic Air Force wonder boy to work on activating the existing command structure and then maybe your fanciful fairytale has a hope of coming true. Until then it’s just more hot air blowing out of Waldrop’s ass.
Best i can say is that the story for late filings was
You don’t have to try.
LOL LOL LOL $EVIO IR LOL LOL LOL - there is no such thing. there is someone (receptionist/ everything is fine, fine fine) who answers the phone. And there is waldrop. thats about it. no idea what glauser and smith do other than collect checks.
willy wally droopy is a micro-manager who will not/ cannot delegate. any assistance or support hires over the past years either bail or get fired.
there have been rumblings of engaging real IR in the past. but rumors are that once the IR audition the company... they walk away. Evio doesnt know how to generate any of the required materials to run a narrative.
All of those simple breezy questions that an engaging IR would convey on a call at every other company in America. Will make waldrop squirm because he doesnt know how to answer them - after the third one hes likely to get defensive and lash out - ego etc.
its a mess. so far the most effective manner of getting them to talk is to goad them on this board/ generate emails asking questions. in the past it seems there is a critical mass that tips the ego and generates an answer.
But this late late late late filing situation seems to have driven waldrop off the deep end. hes reportedly ballooned over 300lbs and the new auditors are ready to quit like the last audotors because he keeps delivering bad docs. 5 years into this.
its a mess
How can we even be certain that the Lab in Canada is still in play? I have pointed out previously that Keystone Labs has removed any mention or logo or link to anything $EVIO related https://keystonelabs.ca/
Now the EVIO site https://eviolabs.com/our-company/locations-2/ has removed any mention of keystone or a testing lab in Canada.
$EVIO has the logos of certification for ISO, Oregon, California but nothing for the GMP for Canada?
I could sort of understand the embarrassment of the Keystone team wanting to hide any association with EVIO on their keystonelabs.ca website (even though that seems completely counter-intuitive as they received a significant chunk of stock in the acquisition deal)
But why EVIO would remove any mention or association with their most expensive acquisition to date. In a jurisdiction that will be shortly seeing edibles and etc coming under testing requirements driving revenues up. Its like $EVIO have gone out of their way to hide the fact they are doing business in Canada at all.
I cant believe that Keystone could force them to do this?
Either $EVIO and willy wally fricktard has lost the lab and is hiding it from shareholders. OR hes succumbed to pressure and threats from keystone to remove any mention of their association. OR $evio management is just business as usual overlooking major and obvious things in their long trip of being the worst.
Also: while there are news storys linked on eviolabs.com regarding Canada and EVIO from 2018. This story "EVIO Canada’s Keystone Labs Ready for Federal Regulatory Cannabis Pesticide Contamination Testing" https://www.biospace.com/article/releases/evio-canada-s-keystone-labs-ready-for-federal-regulatory-cannabis-pesticide-contamination-testing/
from Jan 2, 2019 isnt listed on EVIOs news page. In fact there are no news storys from 2019 on the site. https://eviolabs.com/our-company/news/
Someone on this board immediately disputed any commentary of the removal of all mentions of Keystone from evio and vice versa as being "scare mongering" and cited a source name theyd spoken to in Canada (who was definitely not a name on the keystonelabs.ca masthead) and was assured everything was just fine.
At this point id have to strongly speculate that $evio has lost the Canada lab and shareholders investment in it. Until we get a public statement from either keystone or EVIO saying otherwise,the circumstantial evidence of the name scrubbing and the definitive evidence of ongoing gross negligence by evio management. how could we think otherwise?
260 days late in filing. 245 days delinquent stop sign on $evio stock in 2019. in 104 days they have to file their annual report again. They STILL have three quarterly reports to file - that are all late. Q1-Q2-Q3 2019
Due to criminal negligence President COO Lori GLauser lost the shareholders two licenses in Oregon that cost at least $3,000,000 - California lost. Still no update. MAssachusetts imminent opening... now closing in on ONE WHOLE year of "two weeks away"
The CEO Wally Gumdrop has not issued a PR in MONTHS to update, clarify, explain -
This is a mismanaged pile of garbage company. Thats clear to anyone.
Using language like "basher" or "hater" is just propaganda from people paid off or too stupid to realize theyre being conned by Waldrop and Glauser.
The moment those two toxic lying scum are gone from the deal 90% of the companies problems are gone.
i just dont give a frick about this pos anymore. get it current and im gone. never hear from me again. until then im going to be ripping this pos and pointing to managements ongoing issues with putting their pants on in the morning never mind running a pubco with anything other than naked, selfish disgusting self interest and utter contempt for shareholders and borderline criminal negligence in their fiduciary responsibility.
lol yep 1st prize is a new cadillac. Second prize is a set of steak knives. Third prize is you get fired. Evio already crashed the Cadillac they were handed the keys to in early 2018. The knives are dull and useless. Guess whos up for third place this episode Johnny?
Confusing accountability with negativity is a common error.
American Bar Association: A CEO's relationship with their shareholders carries more legal responsibility than his relationship with his company's creditors.This is because the creditors' relationship with the company exists purely as a result of a legal contract.
The shareholders' relationship with the CEO, by contrast, entails both a binding contract and the trust of that CEO in controlling the shareholders' property.
Fiduciary Duty of Good Faith and Fair Dealing
This fiduciary duty is closely aligned with the duties of care, loyalty, and obedience. Under this duty, officers and directors must act with honesty, good faith, and fairness when handling corporate obligations. This continuing duty runs through their daily tasks and operation of the corporation.
Fiduciary Duty of Disclosure
Candor in business discussion is important between officers, directors, and shareholders so that they may assess material risks and make informed decisions. Full and fair disclosure of material facts is essential before seeking board or stockholder approval of major corporate business transactions, such as a mergers with or acquisitions of other companies. As part of their duties of loyalty and care, officers and directors should also disclose any potential conflict of interest that may arise between their individual interests and those of the corporation.
Fiduciary Duty of Care
In a corporate environment, both officers and directors are expected to use appropriate care and diligence when acting on behalf of their corporation. They should exercise reasonable prudence in carrying out their duties to achieve the best interests of the corporation. An officer or director may be held personally liable for failing to exercise reasonable or ordinary care under the circumstances. For example, a lack of due care may be shown when an officer or director fails to undertake a reasonable review of a corporate matter, to regularly attend board meetings, or to adequately supervise staff which ends up damaging the corporation.
https://www.nolo.com/legal-encyclopedia/fiduciary-responsibility-corporations.html
Learn How to Fill the Form 10-Q Quarterly Report of a Public Company's Performance - provided as a public service for $evio management
Three items to consider when preparing your Quarterly Reports on Form 10-Q to avoid common errors.
1. Rule Changes. Often times, companies take their most recent Form 10-Q or their Form 10-Q from the same fiscal quarter in the prior year and simply update the relevant information. However, the rules and regulations governing filings with the Securities and Exchange Commission are constantly changing, and it is easy for a new rule, rule change or other revision to slip by unnoticed, particularly for in-house counsel who are often working without the resources available to lawyers at private law firms. As a simple example, the infamous Section 4(2) of the Securities Act of 1933 actually changed a couple of years ago to Section 4(a)(2) as a result of the JOBS Act, but this change went unnoticed by many companies whose Form 10-Qs still reference the old Section. In the same vein, changes to the Form 10-Q itself often occur unnoticed. Unfortunately, there are no free reliable resources that compile such changes in a user friendly manner, but the SEC website has recently launched its Rulemaking Index where you can learn about new and proposed rules.
2. Consistency. A Form 10-Q is a cookie jar in which there are many hands. The draft document goes from Accounting to the Business team to Tax to Legal, and all along the way, numbers and text get adjusted, altered and tangled. It is important to remember that if one number or disclosure is changed in the financial footnotes of the Form 10-Q, that the same number or disclosure in the body of the document conforms. Often times, dollar values will be reported in thousands in one section and not in another, which due to rounding, can cause inconsistencies between disclosures in various sections of the Form 10-Q. To avoid this, it may be a good idea to have one person, often times the Controller, be in charge of the document and input comments he or she receives from the various reviewers instead of having many people input their own comments.
3. Exhibits. Most lawyers feel a sense of relief when they come to the exhibit list in their review of the Form 10-Q because it means they are nearing the end of the document. However, it is important to ensure that all exhibits from the quarter that need to be attached are not only listed in the exhibit list, but are attached in full with all applicable schedules, exhibits and conformed signatures, unless the schedules or exhibits are intentionally excluded in accordance with the rules. It is also important to remember to accurately reference the location of prior exhibits that are incorporated by reference into the Form 10-Q. One way of ensuring you don’t forget to include an exhibit on the exhibit list is to keep a running list on your desk throughout the quarter that you can update as documents are signed and agreements are entered into. As you prepare this running list, also consider well in advance whether you will want to seek confidential treatment for any part of an exhibit.
There are of course many moving parts in preparing a Form 10-Q, and these are just a few of the areas where we see common errors.
Three items to consider when preparing your Quarterly Reports on Form 10-Q to avoid common errors.
1. Rule Changes. Often times, companies take their most recent Form 10-Q or their Form 10-Q from the same fiscal quarter in the prior year and simply update the relevant information. However, the rules and regulations governing filings with the Securities and Exchange Commission are constantly changing, and it is easy for a new rule, rule change or other revision to slip by unnoticed, particularly for in-house counsel who are often working without the resources available to lawyers at private law firms. As a simple example, the infamous Section 4(2) of the Securities Act of 1933 actually changed a couple of years ago to Section 4(a)(2) as a result of the JOBS Act, but this change went unnoticed by many companies whose Form 10-Qs still reference the old Section. In the same vein, changes to the Form 10-Q itself often occur unnoticed. Unfortunately, there are no free reliable resources that compile such changes in a user friendly manner, but the SEC website has recently launched its Rulemaking Index where you can learn about new and proposed rules.
2. Consistency. A Form 10-Q is a cookie jar in which there are many hands. The draft document goes from Accounting to the Business team to Tax to Legal, and all along the way, numbers and text get adjusted, altered and tangled. It is important to remember that if one number or disclosure is changed in the financial footnotes of the Form 10-Q, that the same number or disclosure in the body of the document conforms. Often times, dollar values will be reported in thousands in one section and not in another, which due to rounding, can cause inconsistencies between disclosures in various sections of the Form 10-Q. To avoid this, it may be a good idea to have one person, often times the Controller, be in charge of the document and input comments he or she receives from the various reviewers instead of having many people input their own comments.
3. Exhibits. Most lawyers feel a sense of relief when they come to the exhibit list in their review of the Form 10-Q because it means they are nearing the end of the document. However, it is important to ensure that all exhibits from the quarter that need to be attached are not only listed in the exhibit list, but are attached in full with all applicable schedules, exhibits and conformed signatures, unless the schedules or exhibits are intentionally excluded in accordance with the rules. It is also important to remember to accurately reference the location of prior exhibits that are incorporated by reference into the Form 10-Q. One way of ensuring you don’t forget to include an exhibit on the exhibit list is to keep a running list on your desk throughout the quarter that you can update as documents are signed and agreements are entered into. As you prepare this running list, also consider well in advance whether you will want to seek confidential treatment for any part of an exhibit.
There are of course many moving parts in preparing a Form 10-Q, and these are just a few of the areas where we see common errors.
Great opportunity to file a 10-Q - now Seven months late - at this rate the 2019 10K is going to be late - it’s due in 100 days and they still can’t get the three open 10-Qs from 2019 filed.
The level of mismanagement is getting beyond incompetence and crossing over into self destruction. Refuses to provide any shareholder updates or guidance. Doesn’t care about the stock price because theyre busy running the company. Into the ground.
Wow. Project much? How do you know anything if you arent working for the company? How would you know anything more about keystone than anyone here?
There was previously EVIO branding on keystone website, now there is none. Keystone would @evio on social. And now does not. Keystone calls itself "independent" why?
You are slandering me and making huge leaps of assumption. We the shareholders with hundreds of thousands sunk in this deal have zero ACCESS TO INFORMATION and you are making claims to have insider knowledge when your employer Waldrop seeming prefers to share material info with you and not put out press releases.
As much of a coward as he is.
So as an insider apparently receiving material info working actively with Waldrop on his ongoing criminal conspiracy you are refuting the loss of the Keystone lab? But not what is speculated as the loss of the Massachusetts Lab?
The purposeful tanking of deals because Waldrop has lost his mind and is actively sabotaging the deal to serve his own urposes at the expense of shareholders?
4 weeks Monday since 10K was filed. It doesnt take 4 weeks to file Q under normal circumstances. Now over 9 months late and a stop sign EVIO management isnt organized enough to understand the sense of urgency the marketplace demands immediate action? ZERO communication.
Any update on the loss of the Canadian Lab Keystone? ALL mention of EVIO is gone from the keystone website, twitter etc. The Company overview tab states "Keystone is a privately held, independent contract-testing laboratory"
Has EVIO management burned another!! bridge (and several million of shareholders dollars) due to negligence and egregious lack of fiduciary duty to protect shareholder value?
Or has EVIO managed to hang on to their piece of Keystone but their management is regretting ever working with the EVIO clown show and is too embarrassed to have ANY public association with EVIO?
Sad testament to the pathetic EVIO leadership if thats the case.
Keystone recieved a TON of shares in the acquisition deal (along with cash) But youd think that Keystone would be loudly and proudly promoting their EVIO affiliation in Canada to boost shareholder interest and their own personal wealth, considering the last $6m was raised in Canada and a cross list was planned.
Its all very confusing and frustrating. No thanks to the now 9 month stop sign and zero communication for a micro cap pink sheet deal with a senior management team earning $500,000 a year collectively. who cant manage to post a quarterly that they had 9 months to prepare. For what? a million in revenue.
oh and the now 6 weeks since the instagram post from evio MASS flashing an occupancy permit?!?! that IG account was posting daily with staff hires and equipment install being showcased. Now its gone dark. So is that lab lost now? are they carrying a full staff paying rent and financing on $1m in equipment and not open because they "overlooked" details - after the oregon debacle losing $3million and two licenses there late last year?!
Youd almost think that waldrop is actively working to sabotage EVIO on purpose
court case is settled - for another 1mm diluted - shares at 22 cents each
$EVIO News: Current Report Filing (8-k) oh look - a deadbeat getting sued to pay his bills. Where have i heard this $evio tale before?
Still no Mass lab approval and still no Q1 2019 17 days after 2018 10k was released 8 months late. even though youve had 8 months to get a quarterly ready you cant relesase it timely. Cowardly hiding from comment due to mental instability.
Keep up the good work Waldrop. We know we know. its not your fault. never been your fault. ever. dog ate your homework. and we know to not bring up the other subjects of failure due to your flying off into a rage and storming from the room. Makes solving problems of past mistakes impossible. Which is why the same dumb simple garbage gets repeated every month for 5 years now. but its not your fault. we get it.
SMUG is the South Park episode where everyone is farting into wine glasses and inhaling deeply. Over and over they fart and inhale convincing each other that its roses and new born baby smell and not the sulphur and stench of rot. Think $evio management and its mindless cheerleaders on the sidelines and youve got an episode of Smug 2019
Thoughts going forward are that time is short. Time and experience have proven out that Glauser is a clueless moron when it comes to public company management. She is a total writeoff and needs to be gone asasp. Waldrop is bordering on a major breakdown. Hes gained tons of weight and his health is crashing his mental state where hes burrowing more into denial, delegating even less, denying reality even more than usual.
The money men have seen the writing on the wall and have said no more funding until you are gone. Get the filings current and get out of the company. He apparently agreed to these terms back in early 2019 when the "first tranche of 500k" was delivered.
Now it appears he losing his faculties and is even more volatile and lashing out at staff and could be self sabotaging the release of the financials in a sick and twisted fantasy that somehow he can turn everything around and keep his job. OF course none of this is going to happen. Hes too mentally unstable to accept the reality.
We have all seen the fact that Waldrop Glauser have treated their fiduciary responsibility to shareholders as an afterthought over the years. Their contempt for communication, timely filings, breaking the law, covering up crimes are evidence of this laid bare.
The problem is that they believe its "their" company not the "shareholders" and because Waldrop is a vain, petty, weak pathetic version of a human being his ego is too wrapped up in the outside perception of failure to have any understanding that the whole thing is collapsing around him. But hes always been very good at deflecting blame and pointing fingers at every other circumstance except reality.
My guess is $evio is going to be insolvent by november, the share price will crater and the assets will be acquired by competitors and waldrop will be committed to a "facility" the party is over. It was over a while ago.
A real CEO would take the accolades of building out a deal, take their paper and ride into the sunset. Its the way things are done with small cap startups 90% of the time - Waldrop thinks hes zuckerberg and Glauser believes shes the champion of women everywhere. Its like playtime for retards at $evio. You dont have to know how to do the job. Just pretend.
mindless cheerleading pumping nonsense is an opinion to take with a container ships worth of salt. $evio has at least $2 million wrapped up in opening the mass lab for the past 10 months gathering dust and no cash flow.
$evio management waldrop and glauser have had a full staff in Mass now for 3 months. between rent, insurance and wages the burn rate is at least $25,000-$30,000 a month on the non-cash flowing Mass Lab.
Thats at least $75-$90,000 in lost/wasted shareholder cash from a very depleted treasury and counting. A treasury that has lost the income and capital investment of TWO Oregon labs lost to criminal negligence of $evio corporate officers of which to date there have been no repercussions or even comment to address this massive corporate negligence costing shareholders millions in equity.
Anyone glibly saying that another 5 months wont matter is living in a pumpers fantsy world with no relation to the operating reality. Staff will have to be let go, cash is going to be pulled from other operations to just be able to keep the rent paid and the lights on. Oh and the lease payments on a million in non cash flowing equipment.
its just another in a long long line of terrible outcomes as a consequence of avoidable bad terrible lazy short sighted ignorant decisions made by Waldrop and Glauser.
Waldrop Glauser cutting corners. Oregon all over again. Do you think that a team that cheats and lies and coverups to the extent that the $EVIO corporate officers have done (GLauser) in Oregon to the point of losing TWO licenses worth millions of shareholder dollars and 6 months after that gettting caught again for cheating the system and cutting corners on the rules to have their Portland license suspended for 32 days this summer is a team that shareholders, the regulatory bodies can trust?
Since $EVIO management have been paying staff in Massachusetts now for over three months they believed otherwise. Obviously their lazy corner cutting ways have followed them from Oregon and while there are three operating labs for months now in Mass - $EVIO isnt one of them .
lots of paper here waiting on duplicity to pay #500,000 shares
$Evio still has three delinquent quarterly reports outstanding. $EVIO Q1 2019 went delinquent on Feb 15. $EVIO Q2 2019 went delinquent on May 15 and recently $EVIO Q3 2019 went delinquent on August 15. Until these three Q's are filed the company will remain on the pink sheets and keep the stop sign.
Any "blips" in stock volume over the past 8 months that the company has been delinquent in its filings can be tied to news reports of $EVIO Florida's announcements, interviews or activities.
The "pink sheet" crowd you refer too. The college kids and assorted other gamblers playing the .0001 - .0003 can i make enough of this stinky flip to host a kegger blast & thot party this weekend. They mostly all left the $EVIO party when the stock rollback occurred and the big cash raise announced early last year.
$EVIO was given a lot "benefit of the doubt" by a lot of investors for having an angle on what appears to be a catbird seat market positioning of being the only national/international pubco cannabis lab deal around.
Small cap cannabis speculators have had major issues with $EVIO for a very long time because of management. ALan Brochstein ongoing commentary on William Waldrops decision making, ongoing late filings, toxic debt accumulation and close personal business associations with known pump and dump penny pigs like Joseph Wade is but a few examples of many issues brought to light as concerns for many seasoned investors.
From a 2$ a share high in Jan 2018 coming off the $6m raise announcement its been downhill from there as management has confidently aimed the gun at their own foot and just kept pulling the trigger. The lost partnerships, the lost labs, millions wasted on lost acquisitions, the licenses lost in Oregon, the late filings and now of course the STOP sign on $evio pretty much drove away anyone who bought into the narrative as evidenced by the stock price collapse from 2$ to 20 cents
Add on the fact that the company has no investor relations team and doesnt communicate frequently with shareholders, and when they do its mostly opaque in tenor and doesnt typically address the anything of substance. A recipe that doesnt generate much hope in current shareholders or working a narrative to find new ones
Enter $evio FLorida whose fresh look and slick presentation had NBC ABC CBS locally and from around the country talking up testing of CBD - thats the latest round of new investors in the company.
Outside of the tryhard diehards on this board the OTC/small cap marketplace has seen and heard enough of Waldrops bad management, bad decisions, arrogance, incompetence and dictator style to want absolutely nothing to do with $EVIO
This is why you see big blips in trades and weak volume otherwise.
Go back and do the research. the big volume periods can be tracked back to a news story on EVIO - Definitely not news releases BY $EVIO
The only other times there are big volume is when $EVIO management leak material information to friends and insiders who then act on that illegal information to trade ahead of the public to make profits from insider intel.
The trading period around the last week of 2017 is a great example of this. No news was released by the company. No stories were published in the media about the company. It was the week between xmas and new year... yet $EVIO jumped significantly on MASSIVE volume. Why? nobody had a clue. That is Until the $EVIO company PR came out in Feb 2018 announcing the closing of the $6m raise. And guess what. The day back in December 2017 when the volume spiked massively and the price jumped by2x was the day the funding closed.
Taking care of insiders and leaving the shareholders to freeze to death in the wilderness has been the style of management to date. Waldrops one skill is telling the person in front of him exactly what they want to hear to make them happy. Does he have the brainpower, the team infrastructure, the temperament, the delegation skills, the ability and the support and respect of $EVIO employees to make whatever promises he makes reality, HELL NO! LOL
Thats why the incredible turnover of corporate staff and lab staff. His arrogant dismissive seat of the pants house on fire management style just makes so many people used to working with self aware professionals just up and quit. I can speak from experience
Waldrop has commissioned a lot of work and then refuses to pay. Long time board members will remember the NNN post. Many in here complained that it was underhanded of NNN to post a debt collection notice on the board. Trust me. IF youve had the experience in chasing deadbeat Waldrop down for an outstanding debt its an option.
There is no proper corporate structure at $EVIO - there is no mission statement that the team aspires to. There is definitely no delegation, no accounts receivable department. Waldrop micromanages everything to a major fault.
This temperament of personal insecurity bordering on a mental illness of hiding from creditors or ghosting consultants, partnerships and collabs has left a bad taste in the mouth of many in the industry.
Refer back again to the constant exodus of corp officers over the past 18 months. There is a lot more to this story of incompetence, negligence and lies. And thats pretty obvious to anyone when a tiny pink sheet co with 3m in revenue files 8 months late
CBD has been the hottest topic of conversation in 2019 and EVIO isnt in it, major deals going down for brands nationwide in CVS and Safeway and 7-11 etc etc - Wheres $EVIO? certainly NOT announcing multi million dollar / multi year agreements with multiple nationwide CBD brands taking the lead on the market and owning the marketplace.
Thats because once they meet him twice, nobody wants to work with Waldrop again. The one time meet is the charm, the second meet is death
SO while zero announcements of actual major partners are absent from the scene we get the vanity announcement of hemptesting.com / There hasnt been a PR post the release of the K on aug 19 to clarify what the what is going on with the company, its future, its prospects, its status of existence after dipping down to 20 cents and rumors of insolvency flying around, two lost licenses another license suspension, a new california lab in limbo a Massachusetts lab in limbo with millions sunk into both for over a year and no returns for investors.
No PR but we get a tweet and an announcement on Waldrops personal LinkedIn page about hemp testing. More insecurity. More vanity. No client announcements. No press release to tell the world theyre launching hemptesting or cbd testing.
More story to come